Literature DB >> 26210194

Influence of Insulin Resistance Status on the Development of Gallstones Following Roux-En-Y Gastric Bypass: a Prospective Cohort Study.

Everton Cazzo1, Martinho Antonio Gestic2, Murillo Pimentel Utrini2, Ricardo Rossetto Machado2, Laísa Simakawa Jimenez2, Amanda Pinter Carvalheiro da Silva2, Jamal Baracat3, Francisco Callejas-Neto2, José Carlos Pareja2, Elinton Adami Chaim2.   

Abstract

BACKGROUND: The occurrence of gallstones following Roux-en-Y gastric bypass (RYGB) has been extensively reported. As RYGB promotes improvement in insulin resistance (IR), which is one of the factors enrolled in the pathophysiology of gallstones, this study aims to determine the influence of IR and its post-RYGB course on the development of gallstones.
METHODS: This is a prospective cohort study that enrolled 108 morbidly obese subjects free of gallstones which underwent RYGB and were followed up for 24 months, through clinical, laboratory, and ultrasound examinations. IR was assessed through the surrogate marker homeostasis model assessment (HOMA).
RESULTS: Of the individuals evaluated, 29 (26.8%) developed gallstones following RYGB. In the univariate analysis, postsurgical gallstones were associated with preoperative HOMA (p < 0.0001), preoperative fasting glucose (p = 0.0019), preoperative fasting insulin (p = 0.0001), and preoperative triglycerides (p = 0.0001). Multivariate analysis revealed that preoperative HOMA was the only factor independently associated with gallstones (p < 0.0001). The incidence of gallstones among individuals with IR was 46.8%; in the non-IR subjects, the incidence was 7.4% (p < 0.0001). Preoperative IR led to a relative risk of 6.02 (95% CI = 2.1-17.3; p = 0.0009) of gallstones.
CONCLUSIONS: As gallstones often occur following RYGB, there is controversy regarding their management. Some authors propose systematic cholecystectomy along with RYGB, while others suggest that the aggregate risk of the concomitant approach is significantly higher. As IR was a significant risk factor in this study, an individualized approach for this population may be proposed. Further research is needed to confirm these findings.

Entities:  

Keywords:  Bariatric surgery; Gallbladder diseases; Gallstones; Gastric bypass; Insulin resistance; Obesity

Mesh:

Year:  2016        PMID: 26210194     DOI: 10.1007/s11695-015-1815-3

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  48 in total

1.  Changes in GI hormones and their effect on gastric emptying and transit times after Roux-en-Y gastric bypass in rat model.

Authors:  Susumu Suzuki; Eduardo J B Ramos; Carolina G Goncalves; Chung Chen; Michael M Meguid
Journal:  Surgery       Date:  2005-08       Impact factor: 3.982

2.  Is routine cholecystectomy necessary at the time of Roux-en-Y gastric bypass?

Authors:  Jerome Taylor; I Michael Leitman; Michael Horowitz
Journal:  Obes Surg       Date:  2006-06       Impact factor: 4.129

3.  Insulin resistance, inflammation, and the metabolic syndrome following Roux-en-Y gastric bypass surgery in severely obese subjects.

Authors:  Rosa Morínigo; Roser Casamitjana; Salvadora Delgado; Antonio Lacy; Ramon Deulofeu; Ignacio Conget; Silvia Barceló-Batllori; Ramon Gomis; Josep Vidal
Journal:  Diabetes Care       Date:  2007-04-27       Impact factor: 19.112

4.  Gastrointestinal surgery for severe obesity: National Institutes of Health Consensus Development Conference Statement.

Authors: 
Journal:  Am J Clin Nutr       Date:  1992-02       Impact factor: 7.045

Review 5.  Management of gallstones and gallbladder disease in patients undergoing gastric bypass.

Authors:  Bernabé M Quesada; Gustavo Kohan; Hernán E Roff; Carlos M Canullán; Luis T Chiappetta Porras
Journal:  World J Gastroenterol       Date:  2010-05-07       Impact factor: 5.742

6.  Cost-effectiveness analysis of cholecystectomy during Roux-en-Y gastric bypass for morbid obesity.

Authors:  Jaime Benarroch-Gampel; David R Lairson; Casey A Boyd; Kristin M Sheffield; Vivian Ho; Taylor S Riall
Journal:  Surgery       Date:  2012-09       Impact factor: 3.982

7.  Elective cholecystectomy after Roux-en-Y gastric bypass: why should asymptomatic gallstones be treated differently in morbidly obese patients?

Authors:  Daniel E Swartz; Edward L Felix
Journal:  Surg Obes Relat Dis       Date:  2005-09-28       Impact factor: 4.734

8.  How frequently and when do patients undergo cholecystectomy after bariatric surgery?

Authors:  Victor B Tsirline; Zeid M Keilani; Sofiane El Djouzi; Ryan C Phillips; Timothy S Kuwada; Keith Gersin; Connie Simms; Dimitrios Stefanidis
Journal:  Surg Obes Relat Dis       Date:  2013-10-25       Impact factor: 4.734

9.  Gallstone formation after rapid weight loss: a prospective study in patients undergoing gastric bypass surgery for treatment of morbid obesity.

Authors:  M L Shiffman; H J Sugerman; J M Kellum; W H Brewer; E W Moore
Journal:  Am J Gastroenterol       Date:  1991-08       Impact factor: 10.864

10.  Acute pancreatitis in patients after bariatric surgery: incidence, outcomes, and risk factors.

Authors:  Arthi Kumaravel; Andrea Zelisko; Philip Schauer; Rocio Lopez; Matthew Kroh; Tyler Stevens
Journal:  Obes Surg       Date:  2014-12       Impact factor: 4.129

View more
  5 in total

1.  Glucose Metabolism Parameters and Post-Prandial GLP-1 and GLP-2 Release Largely Vary in Several Distinct Situations: a Controlled Comparison Among Individuals with Crohn's Disease and Individuals with Obesity Before and After Bariatric Surgery.

Authors:  Daniéla Oliveira Magro; Everton Cazzo; Paulo Gustavo Kotze; Ana Carolina Junqueira Vasques; Carlos Augusto Real Martinez; Elinton Adami Chaim; Bruno Geloneze; José Carlos Pareja; Cláudio Saddy Rodrigues Coy
Journal:  Obes Surg       Date:  2018-02       Impact factor: 4.129

2.  Depletion of hepatic forkhead box O1 does not affect cholelithiasis in male and female mice.

Authors:  Xiaoyun Feng; Cuiling Zhu; Sojin Lee; Jingyang Gao; Ping Zhu; Jun Yamauchi; Chenglin Pan; Sucha Singh; Shen Qu; Rita Miller; Satdarshan P Monga; Yongde Peng; H Henry Dong
Journal:  J Biol Chem       Date:  2020-04-09       Impact factor: 5.157

3.  Incidence of Symptomatic Cholelithiasis Following Laparoscopic Roux-en-Y Gastric Bypass Is Comparable to Laparoscopic Sleeve Gastrectomy: A Cohort Study.

Authors:  Mahdieh Golzarand; Karamollah Toolabi; Reza Parsaei; Sina Eskandari Delfan
Journal:  Dig Dis Sci       Date:  2021-11-16       Impact factor: 3.487

4.  Risk Factors for Symptomatic Gallstone Disease and Gallstone Formation After Bariatric Surgery.

Authors:  Sylke Haal; Maimoena S S Guman; Sjoerd Bruin; Ruben Schouten; Ruben N van Veen; Paul Fockens; Marcel G W Dijkgraaf; Barbara A Hutten; Victor E A Gerdes; Rogier P Voermans
Journal:  Obes Surg       Date:  2022-02-10       Impact factor: 4.129

5.  The Incidence and Risk Factors of Cholelithiasis Development After Bariatric Surgery in Saudi Arabia: A Two-Center Retrospective Cohort Study.

Authors:  Mohammed A Aldriweesh; Ghadeer L Aljahdali; Edi A Shafaay; Dalal Z Alangari; Nawaf A Alhamied; Hadeel A Alradhi; Amirah S Yaqoub; Sami El-Boghdadly; Omar S Aldibasi; Abdallah A Adlan
Journal:  Front Surg       Date:  2020-10-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.